Source author record

Marcelo Kallmann

Marcelo Kallmann appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

2works
3topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2015arXiv

Simulating the Dynamic Behavior of Shear Thickening Fluids

While significant research has been dedicated to the simulation of fluids, not much attention has been given to exploring new interesting behavior that can be generated with the different types of non-Newtonian fluids with non-constant viscosity. Going in this direction, this paper introduces a computational model for simulating the interesting phenomena observed in non-Newtonian shear thickening fluids, which are fluids where the viscosity increases with increased stress. These fluids have unique and unconventional behavior, and they often appear in real world scenarios such as when sinking in quicksand or when experimenting with popular cornstarch and water mixtures. While interesting behavior of shear thickening fluids can be easily observed in the real world, the most interesting phenomena of these fluids have not been simulated before in computer graphics. The fluid exhibits unique phase changes between solid and liquid states, great impact resistance in its solid state and strong hysteresis effects. Our proposed approach builds on existing non-Newtonian fluid models in computer graphics and introduces an efficient history-based stiffness term that is essential to produce the most interesting shear thickening phenomena. The history-based stiffness is formulated through the use of fractional derivatives, leveraging the fractional calculus ability to depict both the viscoelastic behavior and the history effects of history-dependent systems. Simulations produced by our method are compared against real experiments and the results demonstrate that the proposed model successfully captures key phenomena observed in shear thickening fluids.

preprint2013arXiv

Designing antibiotic cycling strategies by determining and understanding local adaptive landscapes

The evolution of antibiotic resistance among bacteria threatens our continued ability to treat infectious diseases. The need for sustainable strategies to cure bacterial infections has never been greater. So far, all attempts to restore susceptibility after resistance has arisen have been unsuccessful, including restrictions on prescribing [1] and antibiotic cycling [2,3]. Part of the problem may be that those efforts have implemented different classes of unrelated antibiotics, and relied on removal of resistance by random loss of resistance genes from bacterial populations (drift). Here, we show that alternating structurally similar antibiotics can restore susceptibility to antibiotics after resistance has evolved. We found that the resistance phenotypes conferred by variant alleles of the resistance gene encoding the TEM β-lactamase (blaTEM) varied greatly among 15 different β-lactam antibiotics. We captured those differences by characterizing complete adaptive landscapes for the resistance alleles blaTEM-50 and blaTEM-85, each of which differs from its ancestor blaTEM-1 by four mutations. We identified pathways through those landscapes where selection for increased resistance moved in a repeating cycle among a limited set of alleles as antibiotics were alternated. Our results showed that susceptibility to antibiotics can be sustainably renewed by cycling structurally similar antibiotics. We anticipate that these results may provide a conceptual framework for managing antibiotic resistance. This approach may also guide sustainable cycling of the drugs used to treat malaria and HIV.